Upstream Bio UPB Income Statement (2023-2026)

NASDAQ UPB
$5.19 -0.11 (-2.08%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Upstream Bio Quarterly Income Statement

Periods 12 quarters
Latest Jun 2026

Upstream Bio reported revenue of $0.77M and net income of -$39.71M for the quarter ended Jun 2026, down 17.5% year over year. This income statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.) 2.97M2.99M3.00M3.02M3.02M13.68M53.64M53.80M54.00M54.24M54.42M54.77M
Revenue & cost
Revenue 0.62M0.45M0.64M0.51M0.61M0.61M0.57M0.94M0.68M0.67M1.03M0.77M
Gross Profit 0.29M-0.91M-1.57M-2.15M-1.56M-9.06M-1.86M-7.67M-3.94M-3.29M
Operating items
Research & DevelopmentR&D 7.79M11.55M11.69M14.07M15.43M21.77M25.80M37.87M32.98M40.17M36.56M36.09M
Selling, General & AdministrativeSG&A 2.22M3.23M3.96M3.98M4.07M5.16M6.78M7.42M5.54M6.67M8.08M7.05M
Other Operating ExpensesOther Opex 0.46M0.33M0.35M0.84M1.05M1.25M0.89M1.31M1.11M1.19M
Operating ExpensesOpex 10.01M14.78M15.65M18.05M19.50M26.93M32.58M45.28M38.52M46.84M44.65M43.14M
Operating IncomeOp. Inc -9.39M-14.33M-15.01M-17.54M-18.89M-26.32M-32.01M-44.35M-37.83M-46.17M-43.62M-42.37M
EBIT -9.39M-14.33M-15.01M-17.54M-18.89M-26.32M-32.01M-44.35M-37.83M-46.17M-43.62M-42.37M
Non-operating items
Interest & Investment IncomeInt & Inv Inc 1.53M1.52M1.27M2.88M2.90M5.08M4.74M4.43M4.11M3.65M3.05M2.66M
Other Non Operating IncomeOther Non Op Inc. -0.02M-0.01M-0.01M-0.01M-0.00M-0.05M-0.02M0.05M-0.03M0.01M
Non Operating IncomeNon Op. Inc. 6.28M2.50M4.12M2.86M2.90M5.08M4.74M4.38M4.09M3.71M3.02M2.67M
Net income details
EBT -7.86M-12.81M-13.75M-14.66M-15.99M-21.24M-27.27M-39.92M-33.73M-42.51M-40.56M-39.71M
Profit After TaxPAT -7.86M-12.81M-13.75M-14.66M-15.99M-21.24M-27.27M-39.92M-33.73M-42.51M-40.56M-39.71M
Income from Continuing OperationsIncome (Continuing) -7.86M-12.81M-13.75M-14.66M-15.99M-21.24M-27.27M-39.92M-33.73M-42.51M-40.56M-39.71M
Consolidated Net IncomeConsol Net Inc. -7.86M-12.81M-13.75M-14.66M-15.99M-21.24M-27.27M-39.92M-33.73M-42.51M-40.56M-39.71M
Income towards Parent CompanyParent Net Inc -3.10M-11.83M-10.89M-14.68M-15.99M-21.21M-27.27M-39.97M-33.75M-42.44M-40.59M-39.70M
Preferred Dividend PaymentsPref Dividends 3.15M3.15M3.12M4.88M5.04M0.55M
Net Income towards Common StockholdersNet Income -6.25M-14.98M-14.01M-19.56M-21.03M-21.79M-27.27M-39.97M-33.75M-42.46M-40.59M-39.70M
Additional items
EPS (Basic) -2.11-5.07-4.68-6.50-6.96-1.59-0.51-0.74-0.63-0.79-0.75-0.73
EPS (Diluted) -2.11-5.07-4.68-6.50-6.96-1.59-0.51-0.74-0.63-0.79-0.75-0.73
Shares Outstanding 2.96M2.95M3.00M3.01M3.02M13.68M53.62M53.77M53.93M53.85M54.33M54.57M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 2.96M2.95M3.00M3.01M3.02M13.68M53.62M53.77M53.93M53.85M54.33M54.57M
EBITDA -14.32M-15.00M-17.53M-18.88M-26.27M-31.97M-44.30M-37.79M-46.10M-43.57M-42.32M

Upstream Bio Income Statement API

Pull Upstream Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=UPB&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY